In Vitro Stability and Preclinical Safety Evaluation of High-Dose Intravitreal Topotecan in Rabbits: Impact of Dose and Concentration
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Authors
- Fabiana Lubieniecki (ORCID: https://orcid.org/0000-0002-1069-4865)
- Gabriela Lamas (ORCID: https://orcid.org/0000-0002-0582-2535)
- Pablo Nejamkin (ORCID: https://orcid.org/0000-0001-6460-3327)
- David H. Abramson (ORCID: https://orcid.org/0000-0002-0118-6391)
- Paula Schaiquevich (ORCID: https://orcid.org/0000-0002-2568-4731)
- Débora Chan (ORCID: https://orcid.org/0000-0003-0125-7345)
- María José Del Sole (ORCID: https://orcid.org/0000-0002-3896-4425)
- Javier A.W. Opezzo
- Andrés Farrall
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Austral University (AR)
- Universidad de Buenos Aires (AR)
- Garrahan Hospital (AR)
- Universidad Nacional del Centro de la Provincia de Buenos Aires (AR)
Publication Details
- Journal
- Ophthalmology Science
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1016/j.xops.2025.100963
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00